Concepedia

Homare Eda

HE

14

Publications

1.2K

Citations

13

H-Index

2007

Active since

Affiliations

Massachusetts General Hospital(Current)

Harvard University

Dana-Farber Cancer Institute

Acetylon Pharmaceuticals (United States)

Constellation Pharmaceuticals (United States)

Homare Eda is an author at Massachusetts General Hospital specializing in medicine, immunology, and cancer research.

Top concepts

Publications per year

2007–2016

14

Publications

14

Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma

Loredana Santo, Teru Hideshima, Andrew L. Kung et al. · Blood · 2012 · 594 citations · Full text

Ricolinostat (<scp>ACY</scp>‐1215) induced inhibition of aggresome formation accelerates carfilzomib‐induced multiple myeloma cell death

Yuko Mishima, Loredana Santo, Homare Eda et al. · British Journal of Haematology · 2015 · 99 citations

Regulation of Sclerostin Expression in Multiple Myeloma by Dkk-1: A Potential Therapeutic Strategy for Myeloma Bone Disease

Homare Eda, Loredana Santo, Marc N. Wein et al. · Journal of Bone and Mineral Research · 2016 · 98 citations · Full text

Preclinical activity of CPI-0610, a novel small-molecule bromodomain and extra-terminal protein inhibitor in the therapy of multiple myeloma

Ka Tat Siu, Janani Ramachandran, Andrew J. Yee et al. · Leukemia · 2016 · 76 citations

, , +8

In vivo and in vitro effects of a novel anti-Dkk1 neutralizing antibody in multiple myeloma

Samantha Pozzi, Mariateresa Fulciniti, Yan Hua et al. · Bone · 2013 · 71 citations · Full text

, , +6

Rows per page

1–5 of 14